Featured
The Clinical Inflection Point: AI Diagnostics, Funding Shifts, and the Environmental Pathology Paradigm
This week's convergence of FDA AI clearances, NIH funding shifts, microplastic pathology data, mRNA oncology success, and WHO AMR updates reveals a me...
Read Full Story →